Intravitreal bevacizumab as an adjunct in a patient with presumed vascularised choroidal tubercular granuloma.
K
K
Babu
P R
PR
Murthy
K R
KR
Murthy
D000328:Adult; D020533:Angiogenesis Inhibitors / Q000008:administration & dosage*; D000911:Antibodies, Monoclonal / Q000008:administration & dosage*; D061067:Antibodies, Monoclonal, Humanized; D000068258:Bevacizumab; D002829:Choroid / Q000098:blood supply*; D015862:Choroid Diseases / Q000188:drug therapy*; D006801:Humans; D058449:Intravitreal Injections; D008297:Male; D016896:Treatment Outcome; D014375:Tuberculoma / Q000188:drug therapy*; D014391:Tuberculosis, Miliary / Q000150:complications*
D020533:Angiogenesis Inhibitors; D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000068258:Bevacizumab